Serum CA 125 as a tumor marker and the expression of c-erbB-2 oncogene in tubal malignancies

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International Journal of Gynecologic Cancer

• Publication date

  1992-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1525-1438.1993.03020116.xPMID 11578331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease

  2004cited by this paper
• CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube

  2004cited by this paper
• CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube

  2004cited by this paper
• CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.

  1992cited by this paper
• Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports

  1991cited by this paper
• Practical statistics for medical research

  1990cited by this paper
• Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

  1990cited by this paper
• Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses.

  1990cited by this paper
• Fallopian tube cancer: The roswell park experience

  1990cited by this paper
• Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125.

  1990cited by this paper
• Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube

  1990cited by this paper
• CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer.

  1989cited by this paper
• The CA 125 tumour-associated antigen: a review of the literature.

  1989cited by this paper
• Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period.

  1989cited by this paper
• Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Fallopian tube carcinoma: a clinicopathological study of 17 cases.

  1989cited by this paper
• Oncogenes and cancer prognosis.

  1988cited by this paper
• Prognostic Features of Carcinoma of the Fallopian Tube

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• CA-125 in gynecological malignancies.

  1987cited by this paper
• Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case histories.

  1987cited by this paper
• CA 125 for the monitoring of ovarian carcinoma during primary therapy

  1987cited by this paper
• Preoperative Evaluation of Serum CA 125 Levels in Patients With Primary Epithelial Ovarian Cancer

  1986cited by this paper
• Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer —A study on 674 patients—

  1986cited by this paper
• Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix.

  1984cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper
• Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125

  1983cited by this paper
• Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

  1981cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• CLINICAL ASPECTS OF FALLOPIAN TUBE CARCINOMA

  1970cited by this paper
• Reporting results.

  1969cited by this paper
• Primary carcinoma of the fallopian tube.

  1950cited by this paper
• Primary Carcinoma of the Fallopian Tube

  1947cited by this paper

• Carcinoma primario de trompa de Falopio. Presentación de 9 casos

  2004cites this paper
• Carcinoma of the fallopian tube

  2000cites this paper
• Primary fallopian tube cancer: a review of the literature

  1998cites this paper
• Analysis of 23 Cases of Primary Carcinoma of the Fallopian Tube over 50 Years

  1996cites this paper
• Prognostic studies in cancer of the ovary and fallopian tube with emphasis on the CA 125 antigen and c‐erbB‐2 oncogene

  1995cites this paper